MBLY February 2026 Options Begin Trading

Mobileye (MBLY) option ideas: selling the $10.00 put (bid $0.50) implies a net cost basis of $9.50 versus the current $10.60 share price, is ~6% out‑of‑the‑money with a modeled 65% chance to expire worthless and would yield 5.00% on cash committed (41.48% annualized). On the call side, writing the $11.50 covered call (bid $0.30) against shares bought at $10.60 offers an 11.32% total return if called in Feb 2026, the strike is ~8% OTM with a 55% chance to expire worthless and a 2.83% premium boost (23.48% annualized); implied vols are ~70% for the put, 62% for the call, and 59% trailing 12‑month realized.

Analysis

Market structure: The MBLY option prices imply modestly elevated risk premia (IV 62–70% vs realized 59%), rewarding option sellers who collect 2.8–5.0% cash yields to Feb‑2026 (annualized 23–41%). Direct beneficiaries are income-focused retail/prop sellers and buyers willing to be assigned at $9.50; pure upside bulls are disadvantaged by covered‑call caps and potential assignment-driven selling. Elevated single‑name vol suggests concentrated demand for income strategies rather than broad flows.

Risk assessment: Tail risks include a >15% gap down from regulatory, product or partner‑related news that would blow through the $10 put and force assignment; margin squeezes if shares gap lower could cascade. Near term (days–weeks) option Greeks (gamma) can amplify moves into the Feb expiry; medium term (1–3 months) earnings or macro shocks can reprice IV ±10–20 pts; long term fundamentals will dominate equity value if no assignment occurs.

Trade implications: Tactical plays favor defined‑risk income: sell $10/$8 put spreads or buy shares and write the $11.50 Feb call; target position sizing 1–3% NAV per trade and cap downside with protective long puts to limit loss to ~15–20% of NAV on the idea. If you expect IV compression, harvest premium now; if you expect a negative catalyst, avoid naked short puts and prefer spreads or lower delta entries.

Contrarian angles: Consensus treats the 65% expire‑worthless metric as safety, but realized volatility near IV means tail risk is underpriced for asymmetric downside events; selling naked puts without hedges is likely underestimating assignment risk within 60 days. Historical parallels in auto‑tech show frequent >20% mean reversion around earnings, so prefer defined‑risk structures rather than naked income.

Key Decisions for Investors

• Establish a small, defined‑risk income trade: sell-to-open MBLY Feb‑2026 $10 / $8 put spread sizing 1–2% NAV (target net credit $0.35–$0.55); max loss ≈ $1.45–$1.65 per share if assigned — acceptable if willing to own MBLY near $8–10.
• If willing to own the stock, buy MBLY up to 2–3% NAV at market and sell Feb‑2026 $11.50 covered calls for $0.30 (effective upside to $11.80 = +11.3% to call + premium); plan to roll or accept assignment if MBLY > $11.50 within 45–60 days.
• Avoid naked MBLY put sales >3% NAV. If you do sell puts, cap exposure by simultaneously buying a protective put (e.g., buy Feb‑2026 $8 put) or use the put‑spread above to limit tail risk to ~15–20% of position value.
• Monitor two precise triggers over the next 30–45 days: (1) IV move > +10 vol points from current levels (close short premium before earnings), and (2) MBLY closing below $9.00 (buy-to-close short puts or prepare for assignment). Take action within 24 trading hours of either trigger.